• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-FOXO1

FOXO1 Monoclonal Antibody for WB, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

WB, IF, CoIP, ELISA

Conjugaison

Non conjugué

CloneNo.

1D9A2

N° de cat : 66457-1-Ig

Synonymes

FKH1, FKHR, forkhead box O1, Forkhead box protein O1, Forkhead box protein O1A, Forkhead in rhabdomyosarcoma, FOXO1, FOXO1A



Applications testées

Résultats positifs en WBcellules HeLa, cellules HEK-293, cellules L02, cellules SMMC-7721

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:6000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

66457-1-Ig cible FOXO1 dans les applications de WB, IF, CoIP, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéeHumain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène FOXO1 Protéine recombinante Ag13296
Nom complet forkhead box O1
Masse moléculaire calculée 655 aa, 70 kDa
Poids moléculaire observé 70 kDa
Numéro d’acquisition GenBankBC021981
Symbole du gène FOXO1
Identification du gène (NCBI) 2308
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

FOXO1, also named as FOXO1A, FKHR and FKH1, is a member of the FOXO subfamily of Forkhead transcription factors. FOXO1 is a transcription factor which acts as a regulator of cell responses to oxidative stress. FOXO1 interacts with LRPPRC and SIRT1. In the presence of KIRT1, FOXO1 mediates down-regulation of cyclin D1 and up-regulation of CDKN1B levels which are required for cell transition from proliferative growth to quiescence. FOXO1 contains three predicted protein kinase B phosphorylation sites (Thr-24, Ser-256, and Ser-319) that are conserved in other FOXO proteins. The t(2;13) and the variant t(1;13) translocations generate PAX3/FKHR and PAX7/FKHR fusion proteins respectively. The resulting protein is a transcriptional activator. Defects in FOXO1 are a cause of rhabdomyosarcoma type 2 (RMS2).

Protocole

Product Specific Protocols
WB protocol for FOXO1 antibody 66457-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Transl Psychiatry

Psychosocial and behavioral problems of children and adolescents in the early stage of reopening schools after the COVID-19 pandemic: a national cross-sectional study in China.

Authors - Lin Wang
humanWB

Int J Biol Sci

ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.

Authors - Hao Zhang
humanWB

Int Immunopharmacol

1β-Hydroxyalantolactone from Inulae Flos alleviated the progression of pulmonary fibrosis via inhibiting JNK/FOXO1/NF-κB pathway

Authors - Bing Yu
humanWB

Thorac Cancer

Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.

Authors - Xue Wang
  • KD Validated
WB

Equine Vet J

Muscle fibre transition and transcriptional changes of horse skeletal muscles during traditional Mongolian endurance training

Authors - Tugeqin Bou
humanWB,IF,CoIP

Cell Death Dis

SGK2 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating GPX4

Authors - Lulin Cheng
  • KD Validated